阿那莫林2025最新价格是多少钱

Introduction: Anamorelin is a new ghrelin receptor agonist, mainly used to treat weight loss and loss of appetite related to cancer cachexia. This article will introduce in detail the latest price information of the drug in 2025, its global launch status and the necessary preparations before taking the drug, so as to provide patients with a comprehensive medication reference.

What is the latest price of Anamorelin in 2025?

The market price in 2025 will vary depending on the source of the drug, and patients can choose the appropriate version according to the actual situation.

Original drug price

The original drug Anamorelin produced by Japan's Ono Pharmaceutical has a specification of 50mg*100 tablets and a reference price of approximately US$463 per box. Based on a standard dose, monthly treatment costs approximately $463.

Price of generic drugs

The generic drug produced by Lucius in Laos has a specification of 50mg*100 tablets, and the reference price is about US$412 per box. The price of generic drugs is about 11% lower than that of original drugs, providing patients with more choices.

Cross-border purchases also need to consider international shipping costs and possible tariffs. After understanding the price information, it is equally important to understand the global availability of the drug.

Global marketing status of Anamorelin

The current marketing scope of Anamorelin is relatively limited, mainly concentrated in the Japanese market.

Japanese marketing status

In January 2021, Anamorelin was approved for marketing in Japan and will be officially launched in Japan in April 2021. As a Japanese prescription drug, it is currently only distributed in Japanese medical institutions.

Current situation in other countries

As of now, Anamorelin has not been approved for marketing in the United States, the European Union or China, and generic drugs have been launched in a few countries such as Laos.

Current status of generic drugs

There are currently no generic drugs of Anamorelin in the Japanese market. There are only generic versions produced in a few countries such as Laos on the international market, and their quality and efficacy vary.

Preparation for administration of anamorelin

Rational use of anamorelin requires the following preparations.

Confirmation of indications

Before use, a doctor must confirm the weight loss related to cancer cachexia and meet the medication standards. Use without indication may not achieve the expected effect.

Basic examination items

Basic examinations such as blood sugar and electrocardiogram need to be completed before taking medication. Blood sugar levels and heart function need to be monitored regularly during treatment to prevent possible adverse reactions.

Dietary Coordination

During the medication period, it is necessary to maintain a balanced diet and provide appropriate nutritional supplements. It is recommended to record daily diet and weight changes for doctors to evaluate the efficacy.

If symptoms such as palpitations and dizziness occur during treatment, you should seek medical treatment in time. Women of childbearing age should take reliable contraceptive measures.